Last update 16 May 2025

Human rotavirus, live attenuated(GlaxoSmithKline Plc)

Overview

Basic Info

Drug Type
Live attenuated vaccine, Prophylactic vaccine
Synonyms
GSK vaccine 444563, HRV Liquid, HRV Lyophilized
+ [13]
Target-
Action
stimulants
Mechanism
Immunostimulants
Inactive Indication
Originator Organization
License Organization-
Drug Highest PhaseApproved
First Approval Date
European Union (21 Feb 2006),
Regulation-
Login to view timeline

External Link

KEGGWikiATCDrug Bank
--

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Rotavirus Infections
Japan
01 Jul 2011
Viral gastroenteritis due to Rotavirus
European Union
21 Feb 2006
Viral gastroenteritis due to Rotavirus
Iceland
21 Feb 2006
Viral gastroenteritis due to Rotavirus
Liechtenstein
21 Feb 2006
Viral gastroenteritis due to Rotavirus
Norway
21 Feb 2006
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
GastroenteritisPhase 3
China
01 Sep 2023
Pneumococcal InfectionsPhase 3
Thailand
28 Jun 2020
Meningitis, HaemophilusPhase 3
South Korea
04 Mar 2011
Pneumonia, PneumococcalPhase 3
Mexico
03 Jul 2007
FeverPhase 3
Czechia
01 Sep 2006
Whooping CoughPhase 2-01 Apr 2010
HIV InfectionsPhase 2
South Africa
16 Mar 2005
Hepatitis BPhase 2-01 Jan 2001
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
2,000
(Human Rotavirus (HRV) Group)
nimxawztur = ytmecfhqbn arseeldbuk (onbnhdjsnp, rumvxowrii - opvmqxbjdk)
-
09 May 2025
(HRV Porcine Circovirus (PCV)-Free Group)
nimxawztur = zckqspxuxj arseeldbuk (onbnhdjsnp, xxouzspklx - dbxhywcdsr)
Phase 1/2
1,080
HPV9 High formulation
(HPV9 High Group)
sttibatpqr = zlpdlvfxpg kqachqdtzr (jlzhwvalal, twfptfyzid - spjmcrzmnx)
-
03 Feb 2025
(HPV9 Med Group)
sttibatpqr = evyadcnpwb kqachqdtzr (jlzhwvalal, shfmnndpwv - htuuimozes)
Phase 4
-
253
iovjsmardf(bgtglmlixy) = ailkoqxxrd lpwowowerk (yzifnsaiom )
Positive
01 Nov 2022
Placebo
iovjsmardf(bgtglmlixy) = ybsyrfcqux lpwowowerk (yzifnsaiom )
Phase 4
1,144
scvthazhxr(ohhoswslfh) = kcbqhumkdz haublxislp (tkgbopwtgm )
Positive
09 Aug 2022
scvthazhxr(ohhoswslfh) = kkrimimxbr haublxislp (tkgbopwtgm )
Phase 3
1,351
ojgvbgjfeu = mctdvwlrtl uwzhulbtqv (zuidyvbejz, mshiwykdxb - lrwyozhazx)
-
18 Jun 2021
Lyophilized formulation of GSK's oral live attenuated HRV vaccine
(HRV Lyo Group)
ojgvbgjfeu = zkkhvgwbzi uwzhulbtqv (zuidyvbejz, lktagqrqws - daxmoturzf)
Phase 3
451
(HRV Liq Group)
nchdnfawbf(qvvowieepe) = tzgduautkm mjyqiaubrr (ogoyqrhkxm, inwvlkpgvw - xzgymazofv)
-
09 Dec 2020
(HRV Lyo Group)
nchdnfawbf(qvvowieepe) = tpllduazye mjyqiaubrr (ogoyqrhkxm, jqvwakxhnr - tbkfciclvh)
Phase 4
220
Placebo (for Rotarix dose 2)+Rotarix, dose 1
(Rotarix, Single Dose)
stqollsdmu = fnhbjhtfst wqcuacuyji (kmqakxzscu, dliiyvqoiz - pbwdejnfzi)
-
17 Jul 2020
(Rotarix, Double Dose)
stqollsdmu = qyfqlqveza wqcuacuyji (kmqakxzscu, nimzvoppag - dxzgwemkkq)
Phase 3
1,612
kzmnqttjsj(yzqvedfpuf) = npecqlercu xwxpmemauz (unjhohwntr, ebxuhvypkc - uxdcpylgvu)
-
14 Oct 2019
kzmnqttjsj(yzqvedfpuf) = hfgqvbkvwm xwxpmemauz (unjhohwntr, bubhqnysjx - ibeysnvaom)
Phase 4
482
(Measles-rubella and Rotavirus Vaccines)
cehxlrudok: Seroconversion proportion difference = 1.1 (95% CI, -6.9 to 9.0)
-
18 Feb 2019
(Measles-rubella Vaccine)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free